End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.39 MXN | -3.86% | -4.19% | -10.44% |
Strengths
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.44% | 233M | - | C+ | |
+22.21% | 87.14B | C+ | ||
-24.24% | 75.59B | B- | ||
+1.76% | 26.78B | C+ | ||
+3.99% | 17.89B | A- | ||
-14.33% | 16.44B | B | ||
+2.57% | 15.68B | A- | ||
+68.50% | 13.3B | C- | ||
+76.15% | 13.06B | C+ | ||
+3.11% | 12.54B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MEDICA B Stock
- Ratings Médica Sur, S.A.B. de C.V.